Zenas BioPharma Inc. (ZBIO) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Zenas BioPharma Inc.

    NASDAQ: ZBIO · Real-Time Price · USD
    23.03
    1.27 (5.84%)
    At close: Oct 06, 2025, 3:59 PM
    23.03
    0.00%
    After-hours: Oct 06, 2025, 04:10 PM EDT

    Zenas BioPharma Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022
    Net Income
    		 -52.22M -33.57M -52.6M -38.61M -37.98M -27.8M -24.59M 35.61M -29.05M -19.1M -18.99M
    Depreciation & Amortization
    		 -923K 23K 33K 36K 35K 33K 30K 26K 29K 28K 25K
    Stock-Based Compensation
    		 6.04M 5.39M 5.5M 2.84M 1.54M 947K 1.14M 1M 669K 687K 289K
    Other Working Capital
    		 17.25M -11.74M 3.44M 1.15M 5.64M 3.46M 4.45M -3.62M -866K -7.58M 1.51M
    Other Non-Cash Items
    		 200K -29K -344K 125K 291K 853K 455K 173K 10.21M 191K 309K
    Deferred Income Tax
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Change in Working Capital
    		 5.16M -8.86M 8.87M 4.54M 5.16M 6.87M 7.57M -4.96M -2.77M -7.87M 1.24M
    Operating Cash Flow
    		 -41.74M -37.05M -38.55M -31.06M -30.96M -19.1M -15.4M 31.85M -20.91M -26.06M -17.13M
    Capital Expenditures
    		 n/a -18K -74K n/a -35K -22K -17K n/a n/a n/a -1.07M
    Cash Acquisitions
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Purchase of Investments
    		 -126.55M -99.11M -9.66M n/a n/a n/a n/a n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 14.26M 12.86M 6M n/a n/a n/a n/a n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a -26.76M n/a n/a n/a n/a n/a n/a -1M
    Investing Cash Flow
    		 -112.29M -86.27M -3.73M -26.76M -35K -22K -17K n/a n/a n/a -1.07M
    Debt Repayment
    		 n/a n/a n/a n/a n/a n/a n/a 20M n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Financial Acitivies
    		 1.72M n/a -4.4M -439K -766K -656K 50K n/a 11K 55K 59.39M
    Financial Cash Flow
    		 1.72M 99K 1.85M 233.98M 177.74M -614K 50K 20M 11K 55K 59.39M
    Net Cash Flow
    		 -152.55M -123.28M -40.3M 176.11M 146.78M -19.7M -15.45M 51.85M -20.73M -26.01M 41.21M
    Free Cash Flow
    		 -41.74M -37.07M -38.63M -31.06M -30.99M -19.12M -15.42M 31.85M -20.91M -26.06M -18.2M

    Add to Watchlist